Vimarsana
Biggest News Aggregation in the World

Page 6 - Aldx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aldx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aldx Today - Breaking & Trending Today

Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded to "Hold" by StockNews.com - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a report issued on Wednesday. ALDX has been the topic of several other reports. Oppenheimer reaffirmed an outperform rating and issued a $14.00 price objective on shares of Aldeyra Therapeutics in a research report on Wednesday, […]

Source: wkrb13.com
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aldeyra - Vimarsana News

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aldeyra

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra...

Health Care Up on Defensive Bias -- Health Care Roundup - Vimarsana News

Health Care Up on Defensive Bias -- Health Care Roundup

Health-care companies ticked up as traders rotated into sectors less sensitive to the rate of economic growth. Drugmaker Novo Nordisk sued several medical...

Aldeyra Therapeutics (NASDAQ:ALDX) Trading Down 4.2% - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Trading Down 4.2%

Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) traded down 4.2% during trading on Friday . The company traded as low as $10.41 and last traded at $10.41. 377,501 shares were traded during trading, a decline of 49% from the average session volume of 736,787 shares. The stock had previously closed at $10.87. Wall […]

Source: wkrb13.com
Aldeyra Therapeutics' stock jumps 11% premarket after announcing positive trial of treatment for allergic conjunctivitis - Vimarsana News

Aldeyra Therapeutics' stock jumps 11% premarket after announcing positive trial of treatment for allergic conjunctivitis

Aldeyra Therapeutics Inc.’s stock jumped 11% premarket Thursday, after the biotech announced positive results from a late-stage trial of a treatment for...